Therapeutische, antitachykarde Schrittmacher- und Defibrillatortherapie
Reference68 articles.
1. Adler S, Wolpert C, Warman E Musley SK, Koehler JL, Euler DE (2001) Efficacy of pacing therapies for treating atrial tachyarrhythmias in patients with ventricular arrhythmias receiving a dual-chamber implantable cardioverter defibrillator. Circulation 104:887–892 2. Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D (1998) Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98:946–952 3. Boriani G, Padeletti L, Santini M, Pulizia M, Cappucci A, Botto G, Ricci R, Molon G, Accogli M, Vicentini A, Biffi M, Vimercati M, Grammatico A (2005) Predictors of atrial antitachycardia pacing efficacy in patients affected by brady-tachy form of sick sinus syndrome and implanted with a DDDRP device. J Cardiovasc Electrophysiol 16:714–723 4. Boriani G, Wollmann C, Biffi M, Kühl M, Schuchert A, Sperzel J, Stiller S, Gasparini G, Böcker D (2003) Evaluation of a dual chamber implantable cardioverter defibrillator for the treatment of atrial and ventricular arrhythmias. Pacing Clin Electrophysiol 26:461–465 5. Burns JL, Sears SF, Sotile R, Schwartzman DS, Hoyt RH, Alvarez GH, Ujhelyi MR (2004) Do patients accept implantable atrial defibrillation therapy?. Results from the patient atrial shock survey of acceptance and tolerance (PASSAT) study. J Cardiovasc Electrophysiol 15:286–291
|
|